RVAC Medicines Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Out of Business

  • Employees
  • 56

Employees

  • Latest Deal Type
  • Out of Business

RVAC Medicines General Information

Description

Developer of an mRNA platform designed to build a diverse pipeline of innovative medicines. The company provides end-to-end GMP manufacturing capabilities, MSAT infrastructure for process scale-up and tech transfer, and develops single and multi-mRNA/DNA products, enabling healthcare professionals to tackle infectious diseases.

Contact Information

Website
www.rvacmed.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 22-05 Millenia Tower
  • 1 Temasek Avenue
  • Singapore, 039192
  • Singapore
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 22-05 Millenia Tower
  • 1 Temasek Avenue
  • Singapore, 039192
  • Singapore

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RVAC Medicines Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 14-Mar-2026 Completed Out of Business
2. Early Stage VC (Series B) 26-Apr-2022 Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 06-Apr-2022 Completed Pre-Clinical Trials
To view RVAC Medicines’s complete valuation and funding history, request access »

RVAC Medicines Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an mRNA platform designed to build a diverse pipeline of innovative medicines. The company provides end-to-
Drug Discovery
Singapore, Singapore
56 As of 2023

San Francisco, CA
 

Niel, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

RVAC Medicines Competitors (35)

One of RVAC Medicines’s 35 competitors is Vir Biotechnology, a Formerly VC-backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vir Biotechnology Formerly VC-backed San Francisco, CA
etherna Formerly VC-backed Niel, Belgium
Mustang Bio Formerly VC-backed Waltham, MA
Histogen Formerly VC-backed San Ramon, CA
Novavax Corporation Gaithersburg, MD
You’re viewing 5 of 35 competitors. Get the full list »

RVAC Medicines Patents

RVAC Medicines Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025227301-A1 Untranslated regions and uses thereof Pending 28-Apr-2024
EP-4750907-A1 Method of mrna manufacture Pending 26-Jul-2023
WO-2025024734-A1 Method of mrna manufacture Inactive 26-Jul-2023
WO-2025024734-A8 Method of mrna manufacture Inactive 26-Jul-2023
EP-4734981-A1 Ionizable lipids and lipid nanoparticle compositions for delivery of nucleic acids Pending 30-Jun-2023 A61K45/06
To view RVAC Medicines’s complete patent history, request access »

RVAC Medicines Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RVAC Medicines FAQs

  • When was RVAC Medicines founded?

    RVAC Medicines was founded in 2021.

  • Where is RVAC Medicines headquartered?

    RVAC Medicines is headquartered in Singapore, Singapore.

  • What is the size of RVAC Medicines?

    RVAC Medicines has 56 total employees.

  • What industry is RVAC Medicines in?

    RVAC Medicines’s primary industry is Drug Discovery.

  • Is RVAC Medicines a private or public company?

    RVAC Medicines is a Private company.

  • What is RVAC Medicines’s current revenue?

    The current revenue for RVAC Medicines is .

  • Who are RVAC Medicines’s competitors?

    Vir Biotechnology, etherna, Mustang Bio, Histogen, and Novavax are some of the 35 competitors of RVAC Medicines.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process